PharmaCom BioVet Inc (PHMB)
0.00
USD |
OTCM |
Nov 13, 16:00
Price Chart
Key Stats
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.91% |
Profile
PharmaCom BioVet Inc is engaged in locating, identifying, and introducing novel cancer compounds and treatment procedures into the Veterinary Market for companion animals. |
URL | N/A |
Investor Relations URL | N/A |
HQ State/Province | Nevada |
Sector | Health Care |
Industry | Health Care Providers & Services |
Equity Style | N/A |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
PharmaCom BioVet Inc is engaged in locating, identifying, and introducing novel cancer compounds and treatment procedures into the Veterinary Market for companion animals. |
URL | N/A |
Investor Relations URL | N/A |
HQ State/Province | Nevada |
Sector | Health Care |
Industry | Health Care Providers & Services |
Equity Style | N/A |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |